Stoke Therapeutics (STOK) Research & Development (2018 - 2026)
Stoke Therapeutics (STOK) reported Research & Development of $59.83 million for Q3 2026, up 58.7% from $37.7 million a year earlier and up 20.9% from the prior quarter.
Powered by 
Analysis
Stoke Therapeutics (STOK) Research & Development (2018 - 2026) Analysis & Trends
Over the twelve months ended Sep 30, 2026, Stoke Therapeutics' Research & Development came in at $190.7 million, up 59.4% year-over-year; for FY2025, it came in at $137.92 million, up 54.7% from FY2024.
- Research & Development has increased for seven consecutive years, with a five-year compound annual growth rate of 33.8% (FY2020 to FY2025).
- By year, Research & Development came in at $89.13 million in FY2024 (+8.4%), $82.23 million in FY2023 (+5.6%), $77.84 million in FY2022 (+43.7%) and $54.17 million in FY2021 (+68.2%).
- The Q3 2026 figure ranks as the highest quarterly Research & Development in data going back to Q2 2018.
- Year over year, Research & Development has now increased in each of the last 30 quarters, with growth averaging 49.4% over the last eight quarters.
- The year-over-year growth in Research & Development has ranged between 0.8% (Q3 2023) and 91.5% (Q2 2026) over the last five years.
- Per Business Quant data, the three quarters before Q3 2026 came in at $49.5 million (Q2 2026), $39.67 million (Q1 2026) and $41.7 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 4.25 Bn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 4.65 Bn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 2.57 Bn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 4.54 Bn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | 2.85 Bn |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | 4.05 Bn |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 2.11 Bn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 1.61 Bn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 3.02 Bn |
| 10 | Stoke Therapeutics | 1.90 Bn | 658.22 Mn | - | 59.83 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 59.83 Mn |
| Jun 30, 2026 | 49.50 Mn |
| Mar 31, 2026 | 39.67 Mn |
| Dec 31, 2025 | 41.70 Mn |
| Sep 30, 2025 | 37.70 Mn |
| Jun 30, 2025 | 25.86 Mn |
| Mar 31, 2025 | 32.68 Mn |
| Dec 31, 2024 | 23.42 Mn |
| Sep 30, 2024 | 22.21 Mn |
| Jun 30, 2024 | 21.14 Mn |
| Mar 31, 2024 | 22.37 Mn |
| Dec 31, 2023 | 21.78 Mn |
| Sep 30, 2023 | 20.27 Mn |
| Jun 30, 2023 | 20.55 Mn |
| Mar 31, 2023 | 19.63 Mn |
| Dec 31, 2022 | 21.06 Mn |
| Sep 30, 2022 | 20.11 Mn |
| Jun 30, 2022 | 18.36 Mn |
| Mar 31, 2022 | 18.31 Mn |
| Dec 31, 2021 | 15.80 Mn |
API Access
Stoke Therapeutics Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=STOK&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "STOK", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=STOK&period=max&api_key=YOUR_API_KEY");
const data = await res.json();